| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/14756366.2011.622272 |
| P698 | PubMed publication ID | 21999665 |
| P50 | author | Erik W Hartwick | Q85097514 |
| P2093 | author name string | Norman P Curthoys | |
| P2860 | cites work | Isolation, characterization and expression of a human brain mitochondrial glutaminase cDNA | Q22253340 |
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Functional and Structural Characterization of Four Glutaminases from Escherichia coli and Bacillus subtilis † | Q27650545 | ||
| The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 | ||
| THE METABOLISM OF TUMORS IN THE BODY | Q29616202 | ||
| c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 | ||
| Otto Warburg's contributions to current concepts of cancer metabolism | Q29617601 | ||
| Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
| Complexity and species variation of the kidney-type glutaminase gene | Q31066478 | ||
| Targeting mitochondrial glutaminase activity inhibits oncogenic transformation | Q34807996 | ||
| Glutaminase: a hot spot for regulation of cancer cell metabolism? | Q37828397 | ||
| Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) | Q39253539 | ||
| Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. | Q39636555 | ||
| Ehrlich ascites tumor cells expressing anti-sense glutaminase mRNA lose their capacity to evade the mouse immune system | Q40828562 | ||
| Regulation of glutaminase activity and glutamine metabolism | Q40926056 | ||
| Properties of rat renal phosphate-dependent glutaminase coupled to Sepharose. Evidence that dimerization is essential for activation | Q41839361 | ||
| Inhibition by glutamate of phosphate-dependent glutaminase of rat kidney | Q42104953 | ||
| Bacterial expression, purification, and characterization of rat kidney-type mitochondrial glutaminase | Q44578001 | ||
| Phosphate-dependent glutaminase from rat kidney. Cause of increased activity in response to acidosis and identity with glutaminase from other tissues | Q53724073 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 861-867 | |
| P577 | publication date | 2011-10-15 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | BPTES inhibition of hGA(124-551), a truncated form of human kidney-type glutaminase | |
| P478 | volume | 27 |
| Q54943565 | A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines. |
| Q38817911 | Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer |
| Q51138025 | Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators. |
| Q36517216 | Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. |
| Q36749597 | Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation. |
| Q35738138 | Effect of lysine to alanine mutations on the phosphate activation and BPTES inhibition of glutaminase |
| Q37619803 | Expression of glutamine metabolism-related proteins in thyroid cancer |
| Q33834498 | From Krebs to clinic: glutamine metabolism to cancer therapy. |
| Q42364281 | Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition |
| Q37707215 | Glutaminase regulation in cancer cells: a druggable chain of events. |
| Q37684619 | Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes |
| Q38260557 | Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy |
| Q33889353 | Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors |
| Q89401928 | Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase |
| Q27003967 | Rho GTPases and their roles in cancer metabolism |
| Q33587667 | Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration |
| Q41943060 | T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions |
| Q38592248 | Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach |
| Q92932487 | Targeting glutamine metabolism slows soft tissue sarcoma growth |
| Q36868552 | Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders |
| Q64237577 | The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy |
| Q38139096 | Therapeutic strategies impacting cancer cell glutamine metabolism |
| Q38828988 | Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways |
Search more.